Literature DB >> 15823039

Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment.

Mathieu Carpentier1, Willy Morelle, Bernadette Coddeville, Alexandre Pons, Maryse Masson, Joël Mazurier, Dominique Legrand.   

Abstract

Nucleolin is an ubiquitous, nonhistone nucleolar phosphoprotein involved in fundamental aspects of transcription regulation, cell proliferation, and growth. Nucleolin was primarily found in the nucleus, but it was also proposed as a possible shuttle between the nucleus, cytoplasm, and cell membrane. We report here that part of the extranuclear nucleolin undergoes complex N- and O-glycosylations. A band with higher molecular mass (113 kDa) than the 105-kDa classical major nucleolin band was detected on SDS-PAGE gel that cross-reacted with specific anti-nucleolin antibodies and was identified as a nucleolin isoform by mass spectrometry. The presence of N-glycans was first suggested by sensibility of the 113-kDa nucleolin isoform to tunicamycin treatment. Determination of monosaccharide composition by heptafluorobutyrate derivation followed by gas-chromatography mass spectrometry indicated the presence of N- and O-glycans. The structures of N- and O-glycans were first investigated using specificity of binding to lectins. This approach allowed a partial characterization of N-glycan structures and revealed O-glycan structures that could otherwise go unnoticed. Further study of N-glycans by mass spectrometry using direct exoglycosidase treatment on MALDI-TOF target allowed the complete definition of their structures. Finally, the use of peptide mass fingerprinting with sinapinic acid allowed identification of N317 and N492 as the two N-glycosylation sites. N317 and N492 belong to RNA-binding domains 1 and 3 of nucleolin, respectively, that suggests a role of glycosylation in regulating the function of the protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823039     DOI: 10.1021/bi047831s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

2.  Nucleolin mediates the binding of cancer cells to L-selectin under conditions of lymphodynamic shear stress.

Authors:  Tovë M Goldson; Kevin L Turner; Yinan Huang; Grady E Carlson; Emily G Caggiano; Andres F Oberhauser; Susan M Fennewald; Monica M Burdick; Vicente A Resto
Journal:  Am J Physiol Cell Physiol       Date:  2019-10-23       Impact factor: 4.249

3.  Cell surface nucleolin facilitates enterovirus 71 binding and infection.

Authors:  Pei-Yi Su; Ya-Fang Wang; Sheng-Wen Huang; Yu-Chih Lo; Ya-Hui Wang; Shang-Rung Wu; Dar-Bin Shieh; Shun-Hua Chen; Jen-Ren Wang; Ming-Der Lai; Chuan-Fa Chang
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori.

Authors:  Tatsuro Watanabe; Hideaki Tsuge; Takahito Imagawa; Daisuke Kise; Kazuya Hirano; Masatoshi Beppu; Atsushi Takahashi; Kensei Yamaguchi; Hirota Fujiki; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-05       Impact factor: 4.553

5.  Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus.

Authors:  Mohamed Ali Jarboui; Carlo Bidoia; Elena Woods; Barbara Roe; Kieran Wynne; Giuliano Elia; William W Hall; Virginie W Gautier
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

6.  Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.

Authors:  Ara G Hovanessian; Calaiselvy Soundaramourty; Diala El Khoury; Isabelle Nondier; Josette Svab; Bernard Krust
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

7.  Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.

Authors:  Shu Xiao; Elif Caglar; Priscilla Maldonado; Dibash Das; Zaineb Nadeem; Angela Chi; Benjamin Trinité; Xin Li; Anjana Saxena
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

8.  The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.

Authors:  Charalampos Birmpas; Jean Paul Briand; Josẻ Courty; Panagiotis Katsoris
Journal:  Vasc Cell       Date:  2012-12-24

9.  Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.

Authors:  Damien Destouches; Diala El Khoury; Yamina Hamma-Kourbali; Bernard Krust; Patricia Albanese; Panagiotis Katsoris; Gilles Guichard; Jean Paul Briand; José Courty; Ara G Hovanessian
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

10.  Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.

Authors:  Hirota Fujiki; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.